Molecular and serological detection of occult hepatitis B virus among healthy hepatitis B surface antigen-negative blood donors in Malaysia.

BACKGROUND Occult hepatitis B infections are becoming a major global threat, but the available data on its prevalence in various parts of the world are often divergent. OBJECTIVE This study aimed to detect occult hepatitis B virus in hepatitis B surface antigen-negative serum using anti-HBc as a marker of previous infection. PATIENT AND METHODS A total of 1000 randomly selected hepatitis B surface antigen-negative sera from blood donors were tested for hepatitis B core antibody and hepatitis B surface antibody using an ELISA and nested polymerase chain reaction was done using primers specific to the surface gene (S-gene). RESULTS Of the 1000 samples 55 (5.5%) were found to be reactive, of which 87.3% (48/55) were positive for hepatitis B surface antibody, indicating immunity as a result of previous infection however, that does not exclude active infection with escaped mutant HBV. Nested PCR results showed the presence of hepatitis B viral DNA in all the 55 samples that were positive for core protein, which is in agreement with the hepatitis B surface antibody result. CONCLUSION This study reveals the 5.5% prevalence of occult hepatitis B among Malaysian blood donors as well as the reliability of using hepatitis B core antibody in screening for occult hepatitis B infection in low endemic, low socioeconomic settings.

[1]  Z. Sekawi,et al.  Naturally occurring hepatitis B virus surface antigen mutant variants in Malaysian blood donors and vaccinees , 2015, European Journal of Clinical Microbiology & Infectious Diseases.

[2]  F. Mahmoud,et al.  Occult hepatitis B virus infection in children born to HBsAg-positive mothers after neonatal passive-active immunoprophylaxis , 2015, Infection.

[3]  C. Seed,et al.  A method for estimating the residual risk of transfusion‐transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti‐HBc screening , 2013, Vox sanguinis.

[4]  S Hudu,et al.  P24: Occult hepatitis B infection among vaccinated cohort , 2013 .

[5]  H. Ullum,et al.  Infectivity of blood products from donors with occult hepatitis B virus infection , 2013, Transfusion.

[6]  Patricia A. Halon,et al.  Hepatitis B Virus Infection and Immunizations Among Asian American College Students: Infection, Exposure, and Immunity Rates , 2013, Journal of American college health : J of ACH.

[7]  R. Bakry,et al.  Anti-HBc and HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen , 2013 .

[8]  M. Kundi,et al.  Analysis of Mutations in the S Gene of Hepatitis B Virus Strains in Patients with Chronic Infection by Online Bioinformatics Tools , 2012, Journal of Clinical Microbiology.

[9]  H. Alter.  To have B or not to have B: vaccine and the potential eradication of hepatitis B. , 2012, Journal of hepatology.

[10]  Xiaofeng Liang,et al.  An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[11]  Q. Park,et al.  Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors , 2011, Transfusion.

[12]  S. Abdullah.  The effect of repeated blood donations on the iron status of male Saudi blood donors. , 2011, Blood transfusion = Trasfusione del sangue.

[13]  M. Yuen,et al.  Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  R. Crowther,et al.  Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection , 2010, Hepatology.

[15]  X. Teng,et al.  Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. , 2009, The Journal of infection.

[16]  Lei Li,et al.  A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus , 2008, Transfusion.

[17]  M. Rizzetto,et al.  Italian blood donors with anti-HBc and occult hepatitis B virus infection , 2007, Haematologica.

[18]  H. Rosline,et al.  Trends in hepatitis B virus infection among blood donors in Kelantan, Malaysia: a retrospective study. , 2007, The Southeast Asian journal of tropical medicine and public health.

[19]  S. Wiersma,et al.  Progress in the control of hepatitis B infection in the Western Pacific Region. , 2006, Vaccine.

[20]  C. Manegold,et al.  Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen‐negative individuals , 2005, Hepatology.

[21]  H. Blum,et al.  A novel target of hepatitis B virus mutations: Splicing of surface RNA , 2005, Hepatology.

[22]  Wiley Interscience,et al.  Transmission of G145R mutant of HBV to an unrelated contact , 2005, Journal of medical virology.

[23]  B. Weber.  Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. , 2005 .

[24]  K. Soldan,et al.  Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003. , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[25]  K. Soldan,et al.  Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003. , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[26]  K. Ng,et al.  Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia , 2005, Medical Microbiology and Immunology.

[27]  S. Levicnik-Stezinar.  Hepatitis B surface antigen escape mutant in a first time blood donor potentially missed by a routine screening assay. , 2004, Clinical laboratory.

[28]  S. Glynn,et al.  Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti‐HBc: implications for transfusion transmission and donor screening , 2003, Transfusion.

[29]  B. McMahon,et al.  Chronic hepatitis B , 2001, Hepatology.

[30]  C. Bréchot,et al.  Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely “occult”? , 2001, Hepatology.

[31]  E. Tsianos,et al.  Value of anti‐HBc screening of blood donorsfor prevention of HBV infection: results of a 3‐year prospective study in Northwestern Greece , 2001, Transfusion.

[32]  C. Hunt,et al.  Clinical relevance of hepatitis B viral mutations , 2000, Hepatology.

[33]  G. Colucci,et al.  Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection , 2000, Hepatology.

[34]  K. Shimotohno,et al.  Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen , 2000, Hepatology.

[35]  L. Mimms,et al.  The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia , 1997, Hepatology.

[36]  H. Okamoto,et al.  Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen , 1994, Journal of virology.

[37]  R. Purcell,et al.  Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay. , 1989, Proceedings of the National Academy of Sciences of the United States of America.